期刊文献+

卵巢上皮性癌中P-选择素的表达及临床意义 被引量:3

Expression and clinical significance of P-selection in epithelial ovarian carcinoma tissues
下载PDF
导出
摘要 目的探讨研究P-选择素在正常卵巢组织、卵巢良性肿瘤组织、卵巢交界性上皮性肿瘤及卵巢上皮性癌中的表达及与卵巢上皮性癌临床病理特征的关系。方法随机选取吉林大学中日联谊医院和长春市中心医院2008年1月-2009年10月间手术切除的组织标本,其中正常卵巢组织20例、卵巢良性上皮性肿瘤组织20例、卵巢交界性上皮性肿瘤18例和卵巢上皮性癌组织60例。应用免疫组织化学法对组织进行染色,以检测P-选择素的表达情况。结果 (1)P-选择素在不同性质的卵巢组织的细胞膜或细胞浆中均有表达,主要表达于细胞膜中,正常卵巢组织、良性上皮性肿瘤、交界性上皮性肿瘤、上皮性癌中的阳性表达率依次为10.0%、20.0%、27.8%、63.3%,整体之间的阳性表达率比较,差异有显著性。(2)P-选择素在卵巢上皮性癌中的表达随着手术-病理分期和组织病理学分级的升高而增加,而与肿瘤组织学类型无关。结论 (1)P-选择素可能参与卵巢上皮性癌的发生发展,在卵巢恶性肿瘤的发展中起着重要的作用;(2)P-选择素高表达促进了肿瘤的侵袭和转移,表达越高,恶性程度越高、预后越差、越易复发。 Objective To study the expression of P-selection in normal ovarian tissue,benign ovarian tumor,borderline epithelial ovarian tumor and epithelial ovarian carcinoma and its relationship to clinical and pathological features of epithelial ovarian carcinoma.Methods Randomly selecting surgical resection specimens in the China-Japan Union Hopsital of Jilin University and Central Hospital of Changchun between January 2008-October 2009,including 20 cases of normal ovarian tissue,20 cases of benign ovarian epithelial tumors 18 cases of borderline epithelial ovarian tumor and 60 cases of o epithelial ovarian carcinoma,using immunohistochemical method to stain tissues to detect the expression of P-selection.Results(1)P-selectin was all expressed in the membrane and cytoplasm in different types of ovarian tissue,and mainly expressed in the membrane,the positive expression rates of P-selectin were 10.0%,20.0%,27.8%,63.3% respecttively,according to the order of normal ovarian tissues,benign epithelial ovarian tumor,borderline epithelial ovarian tumor and epithelial ovarian carcinomas,the differences between the overall were statistically significant.(2)The positive expression rates of P-selectin in epithelial ovarian cancer increased,as surgical-pathologic staging progressed and histopathologic grade got higher,had no relationship with histological type.Conclusion(1)P-selectin may be involved in the occurrence and development of epithelial ovarian cancer,and plays an important role In the development of epithelial ovarian cancer.(2)The high P-selectin expression may promote the invasion and metastasis proeess of epithelial ovarian cancer,higher P-selectin expression,the higher the degree of malignancy,the worse the prognosis,the more easy to relapse.
出处 《中国实验诊断学》 北大核心 2011年第7期1108-1110,共3页 Chinese Journal of Laboratory Diagnosis
关键词 卵巢上皮性癌 P-选择素 免疫组化 epithelial ovarian carcinoma P-selection Immunohistochemical method
  • 相关文献

参考文献4

  • 1Mastmaga R, Kohno H, Dhar DK, et al. Cyclooxygenase-2 expression cor- relates with tumor neovascularization and prognosis in human colorectal carcinoma patients[J]. Clin Cancer Res,2000,6(7) :4046.
  • 2Ntrmahata K, Satob M, Handa K, et al. Sialosyl-Le (x) expression defines invasive and metastatic properties of bladder carcinoma[ J]. Cancer, 2002, 94(3) :673.
  • 3Borsig L, Wong R, Hynes RO, et al. Synergistic effects of L-and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and impli- cate lellkocytes as enhancers of metastasis[J] .Proc Natl Acad Sci U S A, 2002,99(4) :2193.
  • 4钱思源,王黎娜,刘惠喜.P-选择素在卵巢癌中表达的意义[J].武警医学,2001,12(9):520-522. 被引量:6

二级参考文献1

共引文献5

同被引文献42

  • 1聂宇波,谢海燕.β_2-微球蛋白在肿瘤诊断中的应用[J].赣南医学院学报,2005,25(5):662-662. 被引量:13
  • 2Hensley M L. A step forward for two-step screening for ovarian cancer [J]. J Clin Oncol, 2010, 28(13): 2128- 2130.
  • 3Barbieri R L, In women who have a pelvic mass: Have you tried this new ovarian Ca biomarker? [J]. OBG Managenment, 2010, 22(4):8-12.
  • 4Moore R G, Brown A K, Miller M C, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass [J]. Gynecol Oncol, 2008, 108(2): 402-408.
  • 5Havrilesky L J, Whitehead C M, Rubatt J M, et al. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence [J]. Gynecol Oncol, 2008, 110(3): 374-382.
  • 6Wang Z, Li Y, Banerjee S, et al. Emerging role of Notch in stem cells and cancer [J]. Cancer Lett, 2009, 279(1): 8-12.
  • 7Desmetz C, Maudelonde T, Mange A, et al. Identifying autoantibody signatures in cancer: a promising challenge [J]. Expert Rev Proteomics, 2009, 6(4): 377-386.
  • 8Tan H T, Low J, Lira S G, et al. Serum autoantibodies as biomarkers for early cancer detection [J]. FEBS J, 2009, 276(23): 6880-6904.
  • 9吴冬,王猛,惠宁.卵巢上皮性癌患者血清中HER-2/neu自身抗体的表达及诊断价值[J].第三军医大学学报,2010,31(10):1076-1080.
  • 10张晓霞,王影,黄蓉,李相军,任立群,李荷莲.人激肽释放酶10在卵巢癌组织中的表达及其意义[J].吉林大学学报(医学版),2008,34(4):661-664. 被引量:6

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部